COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series

DOI record: { "DOI": "10.1007/s10067-020-05334-7", "ISSN": [ "0770-3198", "1434-9949" ], "URL": "http://dx.doi.org/10.1007/s10067-020-05334-7", "abstract": "<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Covid-19 infection poses a serious challenge for immune-compromised patients with inflammatory autoimmune systemic diseases. We investigated the clinical-epidemiological findings of 1641 autoimmune systemic disease Italian patients during the Covid-19 pandemic.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>This observational multicenter study included 1641 unselected patients with autoimmune systemic diseases from three Italian geographical areas with different prevalence of Covid-19 [high in north (Emilia Romagna), medium in central (Tuscany), and low in south (Calabria)] by means of telephone 6-week survey. Covid-19 was classified as (1)<jats:italic>definite</jats:italic>diagnosis of Covid-19 disease: presence of symptomatic Covid-19 infection, confirmed by positive oral/nasopharyngeal swabs; (2)<jats:italic>highly suspected</jats:italic>Covid-19 disease: presence of highly suggestive symptoms, in absence of a swab test.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A significantly higher prevalence of patients with<jats:italic>definite</jats:italic>diagnosis of Covid-19 disease<jats:italic>,</jats:italic>or with<jats:italic>highly suspected</jats:italic>Covid-19 disease, or both the conditions together, was observed in the whole autoimmune systemic disease series, compared to “Italian general population” (<jats:italic>p</jats:italic> = .030,<jats:italic>p</jats:italic> = .001,<jats:italic>p</jats:italic> = .000, respectively); and for<jats:italic>definite + highly suspected</jats:italic>diagnosis of Covid-19 disease, in patients with autoimmune systemic diseases of the three regions (<jats:italic>p</jats:italic> = .000, for all comparisons with the respective regional general population)<jats:italic>.</jats:italic>Moreover, significantly higher prevalence of<jats:italic>definite + highly suspected</jats:italic>diagnosis of Covid-19 disease was found either in patients with various “connective tissue diseases” compared to “inflammatory arthritis group” (<jats:italic>p</jats:italic> &lt; .000), or in patients without ongoing conventional synthetic disease-modifying anti-rheumatic drugs treatments (<jats:italic>p</jats:italic> = .011).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The finding of a higher prevalence of Covid-19 in patients with autoimmune systemic diseases is particularly important, suggesting the need to develop valuable prevention/management strategies, and stimulates in-depth investigations to verify the possible interactions between Covid-19 infection and impaired immune-system of autoimmune systemic diseases.<jats:table-wrap><jats:table><jats:tbody><jats:tr><jats:td colspan=\"2\"><jats:bold>Key Points</jats:bold><jats:italic>• Significantly higher prevalence of Covid-19 is observed in a large series of patients with autoimmune systemic diseases compared to the Italian general population, mainly due to patients’ increased susceptibility to infections and favored by the high exposure to the virus at medical facilities before the restriction measures on individual movement.</jats:italic><jats:italic>• The actual prevalence of Covid-19 in autoimmune systemic diseases may be underestimated, possibly due to the wide clinical overlapping between the two conditions, the generally mild Covid-19 disease manifestations, and the limited availability of virological testing.</jats:italic><jats:italic>• Patients with “connective tissue diseases” show a significantly higher prevalence of Covid-19, possibly due to deeper immune-system impairment, with respect to “inflammatory arthritis group”.</jats:italic><jats:italic>• Covid-19 is more frequent in the subgroup of autoimmune systemic diseases patients without ongoing conventional synthetic disease-modifying anti-rheumatic drugs, mainly hydroxyl-chloroquine and methotrexate, which might play some protective role against the most harmful manifestations of Covid-19.</jats:italic></jats:td></jats:tr></jats:tbody></jats:table></jats:table-wrap></jats:p></jats:sec>", "alternative-id": [ "5334" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "26 May 2020" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Revised", "name": "revised", "order": 2, "value": "13 July 2020" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 3, "value": "17 July 2020" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 4, "value": "27 August 2020" }, { "group": { "label": "Compliance with ethical standards", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Disclosures", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "None." } ], "author": [ { "affiliation": [], "family": "Ferri", "given": "Clodoveo", "sequence": "first" }, { "affiliation": [], "family": "Giuggioli", "given": "Dilia", "sequence": "additional" }, { "affiliation": [], "family": "Raimondo", "given": "Vincenzo", "sequence": "additional" }, { "affiliation": [], "family": "L’Andolina", "given": "Massimo", "sequence": "additional" }, { "affiliation": [], "family": "Tavoni", "given": "Antonio", "sequence": "additional" }, { "affiliation": [], "family": "Cecchetti", "given": "Riccardo", "sequence": "additional" }, { "affiliation": [], "family": "Guiducci", "given": "Serena", "sequence": "additional" }, { "affiliation": [], "family": "Ursini", "given": "Francesco", "sequence": "additional" }, { "affiliation": [], "family": "Caminiti", "given": "Maurizio", "sequence": "additional" }, { "affiliation": [], "family": "Varcasia", "given": "Giuseppe", "sequence": "additional" }, { "affiliation": [], "family": "Gigliotti", "given": "Pietro", "sequence": "additional" }, { "affiliation": [], "family": "Pellegrini", "given": "Roberta", "sequence": "additional" }, { "affiliation": [], "family": "Olivo", "given": "Domenico", "sequence": "additional" }, { "affiliation": [], "family": "Colaci", "given": "Michele", "sequence": "additional" }, { "affiliation": [], "family": "Murdaca", "given": "Giuseppe", "sequence": "additional" }, { "affiliation": [], "family": "Brittelli", "given": "Raffaele", "sequence": "additional" }, { "affiliation": [], "family": "Mariano", "given": "Giuseppa Pagano", "sequence": "additional" }, { "affiliation": [], "family": "Spinella", "given": "Amelia", "sequence": "additional" }, { "affiliation": [], "family": "Bellando-Randone", "given": "Silvia", "sequence": "additional" }, { "affiliation": [], "family": "Aiello", "given": "Vincenzo", "sequence": "additional" }, { "affiliation": [], "family": "Bilia", "given": "Silvia", "sequence": "additional" }, { "affiliation": [], "family": "Giannini", "given": "Daiana", "sequence": "additional" }, { "affiliation": [], "family": "Ferrari", "given": "Tommaso", "sequence": "additional" }, { "affiliation": [], "family": "Caminiti", "given": "Rodolfo", "sequence": "additional" }, { "affiliation": [], "family": "Brusi", "given": "Veronica", "sequence": "additional" }, { "affiliation": [], "family": "Meliconi", "given": "Riccardo", "sequence": "additional" }, { "affiliation": [], "family": "Fallahi", "given": "Poupak", "sequence": "additional" }, { "affiliation": [], "family": "Antonelli", "given": "Alessandro", "sequence": "additional" }, { "affiliation": [], "name": "for the COVID-19 & ASD Italian Study Group", "sequence": "additional" } ], "container-title": "Clinical Rheumatology", "container-title-short": "Clin Rheumatol", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2020, 8, 27 ] ], "date-time": "2020-08-27T10:03:57Z", "timestamp": 1598522637000 }, "deposited": { "date-parts": [ [ 2022, 11, 10 ] ], "date-time": "2022-11-10T09:54:38Z", "timestamp": 1668074078000 }, "funder": [ { "DOI": "10.13039/501100007514", "doi-asserted-by": "crossref", "name": "Università di Pisa" } ], "indexed": { "date-parts": [ [ 2024, 5, 17 ] ], "date-time": "2024-05-17T13:40:17Z", "timestamp": 1715953217662 }, "is-referenced-by-count": 96, "issue": "11", "issued": { "date-parts": [ [ 2020, 8, 27 ] ] }, "journal-issue": { "issue": "11", "published-print": { "date-parts": [ [ 2020, 11 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 8, 27 ] ], "date-time": "2020-08-27T00:00:00Z", "timestamp": 1598486400000 } }, { "URL": "https://creativecommons.org/licenses/by/4.0", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 8, 27 ] ], "date-time": "2020-08-27T00:00:00Z", "timestamp": 1598486400000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s10067-020-05334-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s10067-020-05334-7/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s10067-020-05334-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "3195-3204", "prefix": "10.1007", "published": { "date-parts": [ [ 2020, 8, 27 ] ] }, "published-online": { "date-parts": [ [ 2020, 8, 27 ] ] }, "published-print": { "date-parts": [ [ 2020, 11 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1016/j.ijid.2020.03.071", "author": "M Xie", "doi-asserted-by": "publisher", "first-page": "119", "journal-title": "Int J Infect Dis", "key": "5334_CR1", "unstructured": "Xie M, Chen Q (2020) Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis 94:119–124. https://doi.org/10.1016/j.ijid.2020.03.071", "volume": "94", "year": "2020" }, { "DOI": "10.2174/1389202921999200427133052", "author": "A Antonelli", "doi-asserted-by": "publisher", "first-page": "157", "journal-title": "Curr Genomics", "key": "5334_CR2", "unstructured": "Antonelli A, Elia G, Ferrari SM, Foddis R, De Marco S, Cristaudo A, Fallahi P (2020) The Covid-19, epidemiology, Clinic and Prevention. Curr Genomics 21:157–160. https://doi.org/10.2174/1389202921999200427133052", "volume": "21", "year": "2020" }, { "key": "5334_CR3", "unstructured": "WHO. Coronavirus disease 2019 (COVID-19) situation report – 51, 2020. Available: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10. Accessed 11 Mar 2020" }, { "DOI": "10.7861/clinmed.2019-coron", "author": "MA Lake", "doi-asserted-by": "publisher", "first-page": "124", "journal-title": "Clin Med (Lond)", "key": "5334_CR4", "unstructured": "Lake MA (2020) What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond) 20:124–127. https://doi.org/10.7861/clinmed.2019-coron", "volume": "20", "year": "2020" }, { "DOI": "10.1001/jama.2020.1585", "author": "D Wang", "doi-asserted-by": "publisher", "first-page": "1061", "journal-title": "JAMA", "key": "5334_CR5", "unstructured": "Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061. https://doi.org/10.1001/jama.2020.1585", "volume": "323", "year": "2020" }, { "DOI": "10.1056/nejmoa2002032", "author": "WJ Guan", "doi-asserted-by": "publisher", "first-page": "1708", "journal-title": "N Engl J Med", "key": "5334_CR6", "unstructured": "Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19 (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/nejmoa2002032", "volume": "382", "year": "2020" }, { "DOI": "10.1093/cid/cit725", "author": "MJ Memoli", "doi-asserted-by": "publisher", "first-page": "214", "journal-title": "Clin Infect Dis", "key": "5334_CR7", "unstructured": "Memoli MJ, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K, Hagey R, Voell J, Fiorentino C, Ademposi A, Shoham S, Taubenberger JK (2014) The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis 58:214–224. https://doi.org/10.1093/cid/cit725", "volume": "58", "year": "2014" }, { "DOI": "10.1136/annrheumdis-2020-217460", "doi-asserted-by": "publisher", "key": "5334_CR8", "unstructured": "Lu C, Li S, Liu Y (2020) Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19. Ann Rheum Dis:annrheumdis-2020-217460. https://doi.org/10.1136/annrheumdis-2020-217460" }, { "DOI": "10.1016/s2665-9913(20)30095-3", "author": "MA Gianfrancesco", "doi-asserted-by": "publisher", "first-page": "e250", "journal-title": "Lancet Rheumatol", "key": "5334_CR9", "unstructured": "Gianfrancesco MA, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, Sufka P, Grainger R, Wallace Z, Bhana S, Sirotich E, Liew J, Hausmann JS, Costello W, Robinson P, Machado PM, Yazdany J (2020) Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol 2:e250–e253. https://doi.org/10.1016/s2665-9913(20)30095-3", "volume": "2", "year": "2020" }, { "DOI": "10.1016/s0140-6736(20)30628-0", "author": "P Mehta", "doi-asserted-by": "publisher", "first-page": "1033", "journal-title": "Lancet", "key": "5334_CR10", "unstructured": "Mehta P, DF MA, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Speciality Collaboration, UK (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034. https://doi.org/10.1016/s0140-6736(20)30628-0", "volume": "395", "year": "2020" }, { "DOI": "10.1097/cm9.0000000000000819", "doi-asserted-by": "publisher", "key": "5334_CR11", "unstructured": "(2020) Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). (Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 3, 2020). Chin Med J 133:1087–1095. https://doi.org/10.1097/cm9.0000000000000819" }, { "DOI": "10.3760/cma.j.issn.1001-0939.2020.03.009", "author": "Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia", "doi-asserted-by": "publisher", "first-page": "E019", "journal-title": "Zhonghua Jie He He Hu Xi Za Zhi.", "key": "5334_CR12", "unstructured": "Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia (2020) Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:E019. https://doi.org/10.3760/cma.j.issn.1001-0939.2020.03.009", "volume": "43", "year": "2020" }, { "DOI": "10.1016/j.autrev.2020.102539", "author": "D Marotto", "doi-asserted-by": "publisher", "first-page": "102539", "journal-title": "Autoimmun Rev", "key": "5334_CR13", "unstructured": "Marotto D, Sarzi-Puttini P (2020) What is the role of rheumatologists in the era of COVID-19? Autoimmun Rev 19:102539. https://doi.org/10.1016/j.autrev.2020.102539", "volume": "19", "year": "2020" }, { "DOI": "10.55563/clinexprheumatol/r3k9l6", "author": "F Ferro", "doi-asserted-by": "crossref", "first-page": "175", "journal-title": "Clin Exp Rheumatol", "key": "5334_CR14", "unstructured": "Ferro F, Elefante E, Baldini C, Bartoloni E, Puxeddu I, Talarico R, Mosca M, Bombardieri S (2020) COVID-19: the new challenge for rheumatologists. Clin Exp Rheumatol 38:175–180", "volume": "38", "year": "2020" }, { "DOI": "10.1016/j.autrev.2020.102537", "author": "D McGonagle", "doi-asserted-by": "publisher", "first-page": "102537.102537", "journal-title": "Autoimmun Rev", "key": "5334_CR15", "unstructured": "McGonagle D, Sharif K, O'Regan A, Bridgewood C (2020) The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev 19:102537.102537. https://doi.org/10.1016/j.autrev.2020.102537", "volume": "19", "year": "2020" }, { "author": "JWJ Bijlsma", "edition": "3", "key": "5334_CR16", "unstructured": "Bijlsma JWJ, Hachulla E (2018) EULAR textbook on rheumatic diseases, 3rd edn. BMJ Publishing Group, United Kingdom", "volume-title": "EULAR textbook on rheumatic diseases", "year": "2018" }, { "author": "F Riccardo", "key": "5334_CR17", "unstructured": "Riccardo F, Andrianou X, Bella A, Del Manso M, Urdiales AM, Fabiani M et al (2020) Integrated surveillance of COVID-19 in Italy (Epidemia COVID-19). Istituto Superiore di Sanità (ISS), Roma Updating April 28, 2020", "volume-title": "Integrated surveillance of COVID-19 in Italy (Epidemia COVID-19)", "year": "2020" }, { "DOI": "10.1136/annrheumdis-2020-217442", "author": "C Mihai", "doi-asserted-by": "publisher", "first-page": "668", "journal-title": "Ann Rheum Dis", "key": "5334_CR18", "unstructured": "Mihai C, Dobrota R, Schröder M, Garaiman A, Jordan S, Becker MO, Maurer B, Distler O (2020) 2 COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD. Ann Rheum Dis 79:668–669. https://doi.org/10.1136/annrheumdis-2020-217442", "volume": "79", "year": "2020" }, { "DOI": "10.1542/hpeds.2020-0123", "author": "VG Jones", "doi-asserted-by": "publisher", "first-page": "537", "journal-title": "Hosp Pediatr", "key": "5334_CR19", "unstructured": "Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J et al (2020) COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 10:537–540. https://doi.org/10.1542/hpeds.2020-0123", "volume": "10", "year": "2020" }, { "DOI": "10.1136/annrheumdis-2020-217549", "doi-asserted-by": "publisher", "key": "5334_CR20", "unstructured": "Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ et al (2020) Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia. Ann Rheum Dis: annrheumdis-2020-217549. https://doi.org/10.1136/annrheumdis-2020-217549" }, { "DOI": "10.1136/annrheumdis-2020-217549", "doi-asserted-by": "publisher", "key": "5334_CR21", "unstructured": "Beydon M, Chevalier K, Al Tabaa O, Hamroun S, Delettre AS, Thomas M et al (2020) Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis: annrheumdis-2020-217549. https://doi.org/10.1136/annrheumdis-2020-217549" }, { "DOI": "10.1136/annrheumdis-2020-217566", "doi-asserted-by": "publisher", "key": "5334_CR22", "unstructured": "Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B et al (2020) Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis: annrheumdis-2020-217875. https://doi.org/10.1136/annrheumdis-2020-217566" }, { "DOI": "10.1056/nejmc2009567", "author": "R Haberman", "doi-asserted-by": "publisher", "first-page": "85", "journal-title": "N Engl J Med", "key": "5334_CR23", "unstructured": "Haberman R, Axelrad J, Chen A, Castillo R, Yan D, Izmirly P, Neimann A, Adhikari S, Hudesman D, Scher JU (2020) Covid-19 in immune-mediated inflammatory diseases - case series from New York. N Engl J Med 383:85–88. https://doi.org/10.1056/nejmc2009567", "volume": "383", "year": "2020" }, { "DOI": "10.1016/s0140-6736(20)31103-x", "author": "L Verdoni", "doi-asserted-by": "publisher", "first-page": "1771", "journal-title": "Lancet", "key": "5334_CR24", "unstructured": "Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D'Antiga L (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395:1771–1778. https://doi.org/10.1016/s0140-6736(20)31103-x", "volume": "395", "year": "2020" }, { "DOI": "10.1007/s10067-020-05160-x", "author": "C Cheng", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Clin Rheumatol", "key": "5334_CR25", "unstructured": "Cheng C, Li C, Zhao T, Yue J, Yang F, Yan Y, Liu X (2020) COVID-19 with rheumatic diseases: a report of 5 cases. Clin Rheumatol 14:1–5. https://doi.org/10.1007/s10067-020-05160-x", "volume": "14", "year": "2020" }, { "DOI": "10.1136/annrheumdis-2020-217424", "author": "S Monti", "doi-asserted-by": "publisher", "first-page": "667", "journal-title": "Ann Rheum Dis", "key": "5334_CR26", "unstructured": "Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C (2020) Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis 79:667–668. https://doi.org/10.1136/annrheumdis-2020-217424", "volume": "79", "year": "2020" }, { "DOI": "10.1136/annrheumdis-2020-217615", "doi-asserted-by": "publisher", "key": "5334_CR27", "unstructured": "Favalli EG, Ingegnoli F, Cimaz R, Caporali R (2020) What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis annrheumdis-2020-217615. https://doi.org/10.1136/annrheumdis-2020-217615" }, { "DOI": "10.1136/annrheumdis-2020-217717", "doi-asserted-by": "publisher", "key": "5334_CR28", "unstructured": "Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L (2020) COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine. Ann Rheum Dis annrheumdis-2020-217717. https://doi.org/10.1136/annrheumdis-2020-217717" }, { "DOI": "10.1136/annrheumdis-2020-217600", "doi-asserted-by": "publisher", "key": "5334_CR29", "unstructured": "Tomelleri A, Sartorelli S, Campochiaro C, Baldissera EM, Dagna L (2020) Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey. Ann Rheum Dis: annrheumdis-2020-217600. https://doi.org/10.1136/annrheumdis-2020-217600" }, { "DOI": "10.1016/j.autrev.2020.102575", "author": "G Emmi", "doi-asserted-by": "publisher", "first-page": "102575", "journal-title": "Autoimmunity Rev", "key": "5334_CR30", "unstructured": "Emmi G, Bettiol A, Mattioli I, Silvestri E, Di Scala G, Urban ML, Vaglio A, Prisco D (2020) SARS-CoV-2 infection among patients with systemic autoimmune diseases. Autoimmunity Rev 2020:102575. https://doi.org/10.1016/j.autrev.2020.102575", "volume": "2020", "year": "2020" }, { "DOI": "10.1136/annrheumdis-2020-217681", "doi-asserted-by": "publisher", "key": "5334_CR31", "unstructured": "Conticini E, Bargagli E, Bardelli M, Rana GD, Baldi C, Cameli P, Gentileschi S, Bennett D, Falsetti P, Lanzarone N, Bellisai F, Barreca C, D'Alessandro R, Cantarini L, Frediani B (2020) COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs. Ann Rheum Dis:annrheumdis-2020-217681. https://doi.org/10.1136/annrheumdis-2020-217681" }, { "DOI": "10.1016/j.jbspin.2020.05.003", "doi-asserted-by": "publisher", "key": "5334_CR32", "unstructured": "Quartuccio L, Valent F, Pasut E, Tascini C, De Vita S (2020) Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy. Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2020.05.003" }, { "DOI": "10.1016/j.jaut.2020.102502", "doi-asserted-by": "publisher", "key": "5334_CR33", "unstructured": "Zen M, Fuzzi E, Astorri D, Saccon F, Padoan R, Ienna L, Cozzi G, Depascale R, Zanatta E, Gasparotto M, Benvenuti F, Bindoli S, Gatto M, Felicetti M, Ortolan A, Campaniello D, Larosa M, Lorenzin M, Ramonda R, Sfriso P, Schiavon F, Iaccarino L, Doria A (2020) SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients. J Autoimmun 102502. https://doi.org/10.1016/j.jaut.2020.102502" }, { "DOI": "10.1136/annrheumdis-2020-217407", "author": "M Matucci-Cerinic", "doi-asserted-by": "publisher", "first-page": "724", "journal-title": "Ann Rheum Dis", "key": "5334_CR34", "unstructured": "Matucci-Cerinic M, Bruni C, Allanore Y, Clementi M, Dagna L, Damjanov NS, de Paulis A, Denton CP, Distler O, Fox D, Furst DE, Khanna D, Krieg T, Kuwana M, Lee EB, Li M, Pillai S, Wang Y, Zeng X, Taliani G (2020) Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management. Ann Rheum Dis 79:724–726. https://doi.org/10.1136/annrheumdis-2020-217407", "volume": "79", "year": "2020" }, { "DOI": "10.1016/j.autrev.2020.102558", "author": "N Del Papa", "doi-asserted-by": "publisher", "first-page": "102558", "journal-title": "Autoimmun Rev", "key": "5334_CR35", "unstructured": "Del Papa N, Sambataro G, Minniti A, Pignataro F, Caporali R (2020) Novel COronaVirus disease 2019 (COVID-19) epidemic: what are the risks for systemic sclerosis patients? Autoimmun Rev 19:102558. https://doi.org/10.1016/j.autrev.2020.102558", "volume": "19", "year": "2020" } ], "reference-count": 35, "references-count": 35, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s10067-020-05334-7" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "39" }